InvestorsHub Logo
icon url

bbaaller42

06/30/20 3:54 PM

#89148 RE: Jcolt #89144

I agree, but the bloom is off the rose, so to speak. Now it's going to be he said/she said until the results come out. Let's put it this way; through no fault of its own CYDY now has hair on it. Only stunning results can counter these attacks. Mgmt. has no choice but to be in a battle. Shareholders can choose their own future.

I have been through this with OTC stocks before. This is what happens when you don't exist on a legitimate exchange. People sell first, ask questions later. I repeat. I am still long. NP has a major fight on his hands. If there is a decent deal out there, he should think long about accepting it.
icon url

Beachbum3232

06/30/20 4:25 PM

#89182 RE: Jcolt #89144

Couldn't agree with you more. And let's not forget investors in lifescience companies are easily manipulated when talking about clinical trial outcomes. Easy to try and poke holes in study design/enrollment/etc but in the end it's about the results---so longs need to hold the line and not forget why you bought into this company in the first place. It's the science and potential to save lives. In my mind CVD 19 was an unexpected event both for victims and for potential treatments---I was invested in this company long before Covid.

Like you, I bought in because of the other indications leron can treat. This company has a lot going for it which outweighs some erroneous content or content taken out of context being published out there.